A co-owner of a Massachusetts compounding pharmacy whose mold-tainted drugs sparked a deadly fungal meningitis outbreak in 2012 was sentenced on Thursday to one year in prison for deceiving regulators to avoid federal oversight before the tragedy.
China is set to announce an easing of its COVID-19 quarantine protocols in the coming days and a reduction in mass testing, sources say, after anger over the world's toughest curbs fueled widespread protests.
U.S. prosecutors have asked a judge to sentence former Theranos Inc President Ramesh "Sunny" Balwani to 15 years in prison for defrauding investors and patients in the blood-testing startup once led by Elizabeth Holmes.
Pfizer Inc plans to invest more than 1.2 billion euros ($1.26 billion) to expand manufacturing at its plant in Dublin, it said on Thursday, handing the Irish multinational sector a jobs boost at a time when major tech firms are laying off staff.
Biotech firm Roivant Sciences on Thursday launched a company with Pfizer Inc focused on an experimental bowel disease treatment, as the drugmakers seek to tap into a multibillion dollar market.
The near year-long infant formula shortage in the United States that prompted the intervention of the White House is likely to "persist" until spring, according to Reckitt Benckiser, the maker of what is now the biggest brand in the market, Enfamil.
China, the world's top user of pesticides, aims to reduce their use in cultivation of fruit, vegetables and tea by a tenth within three years' time, the farm ministry said on Thursday, in an effort to curb chemicals in the food chain.
China will allow some people who test positive for COVID-19 to quarantine at home, among supplementary measures to be announced in coming days, two sources with knowledge of the matter told Reuters.
As China works to raise COVID-19 vaccination rates among its elderly, essential if the country is to open up again and live with COVID, many older people remain fearful that the treatment will make them sick.
Elon Musk said on Wednesday he expects a wireless brain chip developed by his company Neuralink to begin human clinical trials in six months, after the company missed earlier timelines set by him.
